Company Filing History:
Years Active: 2007-2012
Title: The Innovations of Moshe Flugelman
Introduction
Moshe Flugelman is a prominent inventor based in Haifa, Israel. He has made significant contributions to the field of medical devices, particularly in the development of intravascular prostheses. With a total of 9 patents to his name, Flugelman's work focuses on improving treatments for vascular diseases.
Latest Patents
Flugelman's latest patents include groundbreaking inventions such as drug-eluting intravascular prostheses and methods of use. This invention provides intravascular prostheses that contain an inhibitor of smooth muscle cell proliferation and a growth factor. The device can be coated with a biodegradable drug-eluting polymer, which is impregnated with these crucial components. This innovation is particularly useful for treating or preventing vascular diseases, such as restenosis, by simultaneously inhibiting vessel blockage and enhancing recovery of the vessel wall following an intravascular intervention. Another notable patent involves vectors encoding cell growth and adhesion factors for the simultaneous growth and adhesion of cells. This invention relates to genetically altered endothelial and smooth muscle cells that express or over-express cell adhesion factors, as well as nucleic acid constructs that facilitate the expression of these factors.
Career Highlights
Throughout his career, Moshe Flugelman has worked with various companies, including Multi-Gene Vascular Systems, Ltd. and M.G.V.S. Ltd. His expertise in the field has allowed him to develop innovative solutions that address critical medical challenges.
Collaborations
Flugelman's collaborations with notable colleagues, such as Zoya Gluzman and Meir Preis, have further enhanced his contributions to the field of medical technology. Their combined efforts have led to advancements that benefit patients and healthcare providers alike.
Conclusion
Moshe Flugelman's work exemplifies the impact of innovation in medical technology. His patents and collaborations have paved the way for improved treatments for vascular diseases, showcasing the importance of research and development in healthcare.